Perindopril erbumine Good Manufacturer supply High Quality 107133-36-8
- Molecular Formula:C19H32N2O5.C4H11N
- Molecular Weight:441.612
- Appearance/Colour:white solid
- Melting Point:126-128 °C
- Boiling Point:537.4 °C at 760 mmHg
- Flash Point:278.8 °C
- PSA：121.96000
- Density:1.15 g/cm3
- LogP:3.71330
Perindopril erbumine (107133-36-8) Usage
Perindopril erbumine is a pharmaceutical compound that serves as an angiotensin-converting enzyme (ACE) inhibitor. It is a white solid and is commonly known by the brand name Aceon, which is manufactured by Solvay Pharmaceuticals. Perindopril erbumine is used as a secondary standard for quality control in pharmaceutical laboratories and manufacturing, offering a cost-effective alternative to the preparation of in-house working standards.
How to get the best price on Perindopril erbumine?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of Perindopril erbumine . You can buy high quality, low price Perindopril erbumine 107133-36-8 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
